| Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150 M Ghisi, A Corradin, K Basso, C Frasson, V Serafin, S Mukherjee, ... Blood, The Journal of the American Society of Hematology 117 (26), 7053-7062, 2011 | 266 | 2011 |
| ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia S Peirs, F Matthijssens, S Goossens, I Van de Walle, K Ruggero, ... Blood, The Journal of the American Society of Hematology 124 (25), 3738-3747, 2014 | 250 | 2014 |
| Small noncoding RNAs in cells transformed by human T-cell leukemia virus type 1: a role for a tRNA fragment as a primer for reverse transcriptase K Ruggero, A Guffanti, A Corradin, VK Sharma, G De Bellis, G Corti, ... Journal of virology 88 (7), 3612-3622, 2014 | 142 | 2014 |
| NSD2 is a conserved driver of metastatic prostate cancer progression A Aytes, A Giacobbe, A Mitrofanova, K Ruggero, J Cyrta, J Arriaga, ... Nature communications 9 (1), 5201, 2018 | 89 | 2018 |
| A circulating miRNA assay as a first-line test for prostate cancer screening E Sharova, A Grassi, A Marcer, K Ruggero, F Pinto, P Bassi, P Zanovello, ... British Journal of Cancer 114 (12), 1362-1366, 2016 | 69 | 2016 |
| Epigenetic regulation in prostate cancer progression K Ruggero, S Farran-Matas, A Martinez-Tebar, A Aytes Current molecular biology reports 4, 101-115, 2018 | 65 | 2018 |
| Role of microRNAs in HTLV-1 infection and transformation K Ruggero, A Corradin, P Zanovello, A Amadori, V Bronte, V Ciminale, ... Molecular aspects of medicine 31 (5), 367-382, 2010 | 43 | 2010 |
| Expression of miR-34a in T-cells infected by human T-lymphotropic virus 1 VK Sharma, V Raimondi, K Ruggero, CA Pise-Masison, I Cavallari, ... Frontiers in Microbiology 9, 832, 2018 | 16 | 2018 |
| Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic model H Pais, K Ruggero, J Zhang, O Al-Assar, N Bery, R Bhuller, V Weston, ... Scientific Reports 9 (1), 5760, 2019 | 13 | 2019 |
| LMO2 and IL2RG synergize in thymocytes to mimic the evolution of SCID-X1 gene therapy-associated T-cell leukaemia K Ruggero, O Al-Assar, JS Chambers, R Codrington, T Brend, ... Leukemia 30 (9), 1959-1962, 2016 | 10 | 2016 |
| Modeling antiandrogen resistance in GEM and organoids identifies epigenetic coregulators of AR sensitivity R El Bizri, PS Jiménez, K Ruggero, XW Chen, L Franco, A Semiao, ... European Urology Open Science 56, S53, 2023 | | 2023 |
| The SWI/SNF driven reprograming for the AR cistrome is NSD2 dependent K Ruggero, A Martinez, X Chen, R El Bizri, S Farran, L Palomero, ... Annals of Oncology 30, v806, 2019 | | 2019 |
| Role of FOXM1, CENPF and PARP inhibition in prostate cancer S Farran, K Ruggero, A Martínez, A Aytes European Urology Supplements 17 (2), e367, 2018 | | 2018 |
| Epigenetic mechanisms and therapeutic opportunities in metastatic castration resistant prostate cancer K Ruggero, A Giacobbe, A Mitrofanova, A Calvet, L Palomero, MA Pujana, ... European Urology Supplements 3 (16), e249-e250, 2017 | | 2017 |
| Weatherall Institute of Molecular Medicine MRC Molecular Haematology Unit University of Oxford, John Radcliffe Hospital. Oxford K Ruggero, O Al-Assar, JS Chambers, R Codrington, T Brend, ... | | 2016 |
| Pre-clinical Modelling of Chromosomal Translocations and Inversions K Ruggero, TH Rabbitts Chromosomal Translocations and Genome Rearrangements in Cancer, 429-445, 2015 | | 2015 |
| Role of microRNAs in T-cell activation and transformation by human T-cell Leukemia virus type 1 K Ruggero Università degli studi di Padova, 2012 | | 2012 |
| MicroRNA expression in HTLV-1 infection and pathogenesis DM D'Agostino, K Ruggero, M Biasiolo, S Bortoluzzi, CA Pise-Masison, ... Retrovirology 8, 1-1, 2011 | | 2011 |
